ADITUM BIO
Aditum Bio is an investment fund that specializes in acquiring and developing pharmaceutical assets. It gives patients access to medicines that may not otherwise be developed. Aditum Bio was founded on 2019 and is headquartered in San Francisco, California.
ADITUM BIO
Industry:
Health Care Medical Therapeutics Venture Capital
Founded:
2019-01-01
Status:
Active
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Current Employees Featured
Ilan Zipkin Partner and VP, Business Development and Licensing @ Aditum Bio
Partner and VP, Business Development and Licensing
2019-01-01
Joe Jimenez Co-Founder and Managing Director @ Aditum Bio
Co-Founder and Managing Director
2019-08-01
Susie Phillips Executive Assistant @ Aditum Bio
Executive Assistant
2019-01-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-12-15 | Anteris Bio | Anteris Bio acquired by Aditum Bio | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-08 | Hubpay | Aditum Bio investment in Series A - Hubpay | 20 M USD |
| 2021-09-07 | Via Nova Therapeutics | Aditum Bio investment in Series A - Via Nova Therapeutics | 20 M USD |
| 2021-08-31 | Versanis Bio | Aditum Bio investment in Series A - Versanis Bio | 70 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-08 | Aditum Bio announces the appointment of Stephen Kanes, M.D. Ph.D., as Chief Executive Officer of Ancora Bio |
More informations about "Aditum Bio"
About | Aditum Bio | Biotechnology Assets to Benefit Patients
Aditum Bio brings together unmatched scientific and domain expertise with agile operational capabilities. Our unique investment and operating model enables rapid company formation, …See details»
Aditum Bio - Crunchbase Investor Profile & Investments
Aditum Bio is an investment fund that specializes in acquiring and developing pharmaceutical assets. It gives patients access to medicines that may not …See details»
Aditum Bio - Investments, Portfolio & Company Exits - Crunchbase
Aditum Bio has made 4 investments. Their most recent investment was on Mar 24, 2025 , when Tempero Bio raised $70M . How many investments has this organization made over time?See details»
Novartis alums Jimenez, Fishman unveil their next act: …
Nov 2, 2020 Aditum’s first spinout, Teres Bio, is working on treatments for atopic dermatitis and plaque psoriasis, while its second, Tempero Bio, is developing …See details»
Aditum Bio investment portfolio - PitchBook
Aditum Bio's latest investment was on 08-May-2023 in Vitalli Bio, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting the most accurate …See details»
Aditum finds twist on old idea, paying $10M for BTK …
Apr 28, 2023 Aditum Bio has created Vitalli Bio, its ninth portfolio company, to take the drug candidate into the clinic. Human tests of the oral molecule, now renamed VIT-801, are expected to start later this ...See details»
Portfolio | Aditum Bio | Biotechnology Assets to Benefit …
Aditum Bio is harnessing our unique investment approach focused on the translational stage of drug development, combined with our agile operating model for company formation and trial execution, Aditum Bio has launched seven …See details»
Aditum Bio - teaserclub.com
Aditum Bio is a venture capital investment firm founded in 2019 and headquartered in San Francisco, California. The firm specializes in acquiring and developing pharmaceutical assets, …See details»
Aditum Bio | Institution Profile - Private Equity International
Aditum Bio. News, insights, analysis and data. Aditum Bio overview. Founded in 2019, Aditum Bio is a California-based Independent firm that focuses on biotech investments across the United …See details»
Aditum Bio - Funding, Financials, Valuation & Investors - Crunchbase
Aditum Bio has raised a single venture fund, Aditum Bio Fund 1, L.P.. Funds Raised. Edit Funds Raised Section. Number of Funds 1. Aditum Bio has raised a single venture fund, Aditum Bio …See details»
Aditum Bio Announces Formation of Third Company, Anteris Bio
Aditum Bio focuses on basic mechanisms of disease, in-licenses promising drug candidates directed at such pathophysiologies, and spins-out individual companies dedicated to bringing …See details»
Job Application for Senior Director, Clinical Development at …
Company Overview . At Aditum Bio our mission is to provide access to medicines to patients in need. Co-founded by industry veterans Joe Jimenez, former CEO of Novartis and Mark …See details»
People | Aditum Bio | Biotechnology Assets to Benefit Patients
Aditum Bio has brought together a renowned, highly credentialed leadership team with the vision, expertise, and ambition to deliver on the promise of our new model of biotech venture capital.See details»
Novartis alums Jimenez, Fishman unveil their next act: Aditum Bio
Nov 3, 2020 Now, he’s unveiling that something: Aditum Bio, a biotech investment firm he co-founded with Mark Fishman, M.D., former president of the Novartis Institutes for BioMedical …See details»
Aditum Bio - workinbiotech.com
Aditum Bio is a new model of biotech venture capital that is focused on acquiring and translating scientific discoveries into innovative therapies. The three words that best describe Aditum’s …See details»
Approach | Aditum Bio | Biotechnology Assets to Benefit Patients
Aditum Bio’s strategic advantage extends to its proven acumen for using an array of powerful technologies and digital tools throughout its portfolio companies to support clinical trial …See details»
VC Aditum Bio hatches autoimmune-focused Oblenio Bio with …
Nov 7, 2024 Jimenez served as CEO of Novartis for eight years before founding Aditum in 2019 with another Big Pharma alum, Mark Fishman, M.D., who was president of the Novartis …See details»
Aditum Bio - Contacts, Employees, Board Members, Advisors
Aditum Bio has 4 current employee profiles, including Partner and VP, Business Development and Licensing Ilan Zipkin. Contacts. Edit Contacts Section. Job Department. Protected Content. …See details»
Establishing Canada’s first large-scale bioinnovation centre
Mar 20, 2025 Today, the Honourable Darren Fisher, Member of Parliament for Dartmouth – Cole Harbour, announced a $5 million, non-repayable contribution to Neptune BioInnovation Inc. to …See details»
Values | Aditum Bio | Biotechnology Assets to Benefit Patients
Aditum Bio is a new breed of biotech investment firm that is driven to translate science into the new medicines that make a meaningful difference in the lives of patients. We are a dedicated …See details»